To further examine the mechanisms by which KLF5 expression leads to a poorer prognosis in pancreatic cancer patients, we identified the microRNAs activated by KLF5 and their target genes and evaluated their roles in the pancreatic cancer pathway extracted in KEGG. This evidence concerns the gene KLF5 and familial pancreatic carcinoma.